Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WSC 2026 | DAPT vs thrombolysis in acute non-disabling stroke: is it a fair comparison?

S. Claiborne Johnston • 21 Oct 2026
WSC 2026
Acute Ischemic Stroke Stroke

S. Claiborne Johnston, MD, PhD, Harbor Health, Austin, TX, and UCSF, San Francisco, CA, discusses the use of dual antiplatelet therapy (DAPT) and thrombolysis for patients with non-disabling ischemic stroke. Dr Johnston explains that it is not a fair comparison as they have different roles, but trials have suggested thrombolysis is not effective in these patients. This interview took place at the 18th World Stroke Congress (WSC) in Seoul, Korea.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from S. Claiborne Johnston

The future of factor XI inhibitors in secondary stroke prevention: asundexian and beyond
3:49
The future of factor XI inhibitors in secondary stroke prevention: asundexian and beyond
S. Claiborne Johnston • 21 Oct 2026
CHANCE-2: ticagrelor versus clopidogrel in CYP2C19 allele carriers
1:44
CHANCE-2: ticagrelor versus clopidogrel in CYP2C19 allele carriers
S. Claiborne Johnston • 7 Sep 2021
Ischemic benefit vs. hemorrhagic risk in the THALES dual antiplatelet therapy trial
2:05
Ischemic benefit vs. hemorrhagic risk in the THALES dual antiplatelet therapy trial
S. Claiborne Johnston • 7 Sep 2021

Related Videos

The future of factor XI inhibitors in secondary stroke prevention: asundexian and beyond
3:49
The future of factor XI inhibitors in secondary stroke prevention: asundexian and beyond
S. Claiborne Johnston • 21 Oct 2026
The human face of recurrent stroke: beyond physical outcomes
1:29
The human face of recurrent stroke: beyond physical outcomes
Mike Sharma • 21 Oct 2026
Lessons from TECNO: what next for intra-arterial thrombolysis trials in ischemic stroke?
1:47
Lessons from TECNO: what next for intra-arterial thrombolysis trials in ischemic stroke?
Adnan Mujanovic • 21 Oct 2026
Advances in CVST: endovascular treatment, imaging and antiphospholipid syndrome
1:03
Advances in CVST: endovascular treatment, imaging and antiphospholipid syndrome
Ronen Leker • 21 Oct 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals